Summary
The synthesis of dopamine was determined as the accumulation of Dopa after Dopa decarboxylase inhibition. The release of dopamine was determined as the disappearance of the amine after treatment with the tyrosine hydroxylase inhibitor α-methyltyrosine. These processes were not significantly changed in the rat brain by pentobarbital sodium anaesthesia or by 10 min halothane anaesthesia. The accelerations of the dopamine synthesis and release after treatment with haloperidol were markedly reduced during pentobarbital, but not halothane anaesthesia. Anaesthesia with pentobarbital did not affect the increased synthesis and release of dopamine observed when the dopaminergic nerve terminals were depolarized by local treatment with KCl. The increases in dopamine synthesis and concentration after axotomy were similar whether the operation was performed during pentobarbital or halothane anaesthesia. It is suggested that the selective reduction of the haloperidol-induced effects by pentobarbital may be due to interference with a neuronal feedback loop.
Similar content being viewed by others
References
Andén, N.-E., Bédard, P., Fuxe, K., Ungerstedt, U.: Early and selective increase in brain dopamine levels after axotomy. Experientia (Basel) 28, 300–301 (1972)
Andén, N.-E., Corrodi, H., Dahlström, A., Fuxe, K., Hökfelt, T.: Effects of tyrosine hydroxylase inhibition on the amine levels of central monoamine neurons. Life Sci. 5, 605–611 (1966a)
Andén, N.-E., Corrodi, H., Fuxe, K., Ungerstedt, U.: Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons. Europ. J. Pharmacol. 15, 193–199 (1971)
Andén, N.-E., Dahlström, A., Fuxe, K., Hökfelt, T.: The effect of haloperidol and chlorpromazine on the amine levels of central monoamine neurons. Acta physiol. scand. 68, 419–420 (1966b)
Bertler, Å., Carlsson, A., Rosengren, E.: A method for the fluorimetric determination of adrenaline and noradrenaline in tissue. Acta physiol. scand. 44, 273–292 (1958)
Bloom, F. E., Costa, E., Salmoiraghi, G. C.: Anaesthesia and the responsiveness of individual neurons of the caudate nucleus of the cat to acetylcholine, norepinephrine and dopamine administered by microelectrophoresis. J. Pharmacol. exp. Ther. 150, 244–252 (1965)
Bunney, B. S., Walters, J. R., Roth, R. H., Aghajanian, G. K.: Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. exp. Ther. 185, 560–571 (1973)
Carlsson, A., Davis, J. N., Kehr, W., Lindqvist, M., Atack, C. V.: Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 153–168 (1972)
Carlsson, A., Lindqvist, M.: In-vivo decarboxylation of α-methyl DOPA and α-methyl metatyrosine. Acta physiol. scand. 54, 87–94 (1962)
Carlsson, A., Lindqvist, M.: Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta pharmacol. (Kbh.) 20, 140–144 (1963)
Carlsson, A., Waldeck, B.: A fluorimetric method for the determination of dopamine (3-hydroxytyramine). Acta physiol. scand. 44, 293–298 (1958)
Corrodi, H., Fuxe, K., Hökfelt, T.: The effects of barbiturates on the activity of the catecholamine neurones in the rat brain. J. Pharm. Pharmacol. 18, 556–558 (1966)
Corrodi, H., Hanson, L. C. F.: Central effects of an inhibitor of tyrosine hydroxylation. Psychopharmacologia (Berl.) 10, 116–125 (1966)
Hassler, R., Bak, I. J.: Unbalanced ratios of striatal dopamine and serotonin after experimental interruption of strionigral connections in rat. In: F. J. Gillingham, I. M. L. Donaldson: Third symposium on Parkinson's disease, pp. 29–37. Edinburgh-London: Livingstone 1969
Kehr, W., Carlsson, A., Lindqvist, M.: A method for the determination of 3,4-dihydroxyphenylalanine (Dopa) in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 273–280 (1972b)
Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., Atack, C.: Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. J. Pharm. Pharmacol. 24, 744–747 (1972a)
Lidbrink, P., Corrodi, H., Fuxe, K., Olson, L.: Barbiturates and meprobamate: decreases in catecholamine turnover of central dopamine and noradrenaline neuronal systems and the influence of immobilization stress. Brain Res. 45, 507–524 (1972)
Lidbrink, P., Farnebo, L.-O.: Uptake and release of noradrenaline in rat cerebral cortex in vitro: no effect of benzodiazepines and barbiturates. Neuropharmacology 12, 1087–1095 (1973)
Lindqvist, M., Carlsson, A., Kehr, W.: Influence of anaesthetics on tyrosine and tryptophan hydroxylation in rat brain in vivo. Acta physiol. scand., Suppl. 396, 57 (1973)
Nybäck, H., Borzecki, Z., Sedvall, G.: Accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain; effect of some psychotropic drugs. Europ. J. Pharmacol. 4, 395–403 (1968)
Persson, T.: Drug induced changes in 3H-catecholamine accumulation after 3H-tyrosine. Acta pharmacol. (Kbh.) 28, 378–390 (1970)
Persson, T., Waldeck, B.: A reduced rate of turnover of brain noradrenaline during pentobarbitone anaesthesia. J. Pharm. Pharmacol. 23, 377–378 (1971)
Roth, R. H.: Inhibition by γ-hydroxybutyrate of chlorpromazine-induced increase in homovanillic acid. Brit. J. Pharmacol. 47, 408–414 (1973)
Sharpless, S. K.: Hypnotics and sedatives. I. The barbiturates. In: L. S. Goodman and A. Gilman: The pharmacological basis of therapeutics, pp. 98–120. New York: MacMillan 1970
Spector, S., Sjoerdsma, A., Udenfriend, S.: Blockade of endogenous norepinephrine synthesis by α-methyltyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. exp. Ther. 147, 86–95 (1965)
Stock, G., Magnusson, T., Andén, N.-E.: Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow. Naunyn-Schmiederberg's Arch. Pharmacol. 278, 347–361 (1973)
Walters, J. R., Roth, R. H., Aghajanian, G. K.: Dopaminergic neurons: similar biochemical and histochemical effects of γ-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway. J. Pharmacol. exp. Ther. 186, 630–639 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andén, NE., Magnusson, T. & Stock, G. Effect of anaesthetic agents on the synthesis and disappearance of brain dopamine normally and after haloperidol, KCl or axotomy. Naunyn-Schmiedeberg's Arch. Pharmacol. 283, 409–418 (1974). https://doi.org/10.1007/BF00501113
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00501113